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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296S27025.6%, 55.3%), and 55.6% for L5S1 (95% CI¼ 43.3%, 67.2%); two level FJAwas
not observed. The prevalence was signiﬁcantly greater at the L5S1 level for
symptomatic FJA than asymptomatic FJOA (p<0.01); the rates were not
signiﬁcantly different at level L45 (p¼0.49). Comparisons were not per-
formed at other levels since FJA/FJOA was not observed in both groups.
Conclusion: CLBP due to FJA most commonly occurs at L5S1. Morphologic
abnormalities indicative of FJOA in asymptomatic adults occur most
commonly at L45. These ﬁndings suggest that arthritic changes alone are
not the sole etiologic factor mitigating FJA related CLBP.
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LAMIN A DEREGULATION IN HUMAN MESENCHYMAL STEM CELLS
PROMOTES AN IMPAIRMENT IN THEIR CHONDROGENIC POTENTIAL
AND IMBALANCE IN THEIR RESPONSE TO OXIDATIVE STRESS
J. Mateos 1, A. De la Fuente 2, I.A. Lesende-Rodríguez 2, M. Arufe 2,3,
F.J. Blanco 1,3. 1Rheumatology Div., Proteomics Unit-ProteoRed/ISCIII INIBIC-
CHUAC, A Coruña, Spain; 2Dept. of Med., Area of Anatomy and Human
Embryology, University of A Coruña, Spain; 3Rheumatology Div., Cellular
Therapy Unit, CIBER-BBN/ISCIII, INIBIC-CHUAC, A Coruña, Spain
Purpose: Previous work by our group and others indicated that an accumu-
lation of lamin A (LMNA) was associated with the osteoarthritis (OA) chon-
drocyte phenotype. Mutations of this protein are linked to laminopathies and
speciﬁcally to Hutchinson-Guilford Progeria Syndrome (HGPS), an accelerated
agingdisease. Someauthorshaveproposed that aderegulationof LMNAaffects
the differentiation potential of stem cells. In the present study, we examined
the effect of the over-expression of LMNA, or itsmutant formprogerin (PG), on
the mesoderm differentiation potential of MSCs.
Methods:Mesenchymal stem cells (MSCs) from human umbilical cord (UC)
stroma have previously been isolated, expanded and differentiated towards
mesoderm cell lineages. For efﬁcient gene delivery of wt LMNA, PG and GFP
(Green Fluorescence Protein), we used a lentiviral expression system. GFP-
transducedMSCswereusedas control for thedifferentiation study since they
present a differentiation capacity similar to that of untransduced MSCs.
Osteogenic potential was studied by with alizarin red staining to assess
calcium deposits as well as Real-Time PCR of ALP, OC and Runx2 to assess
early and late osteogenic differentiation. Adipogenic potential was studied
with Oil Red staining for lipid droplets and Real-Time PCR of LPL, FABP and
ADIPOQ, for early and late adipogenic differentiation. Chondrogenesis and
hypertrophywere studied using immunohistochemestry and Real-Time PCR
of Aggrecan, MMP-13, Type II Collagen, Type I Collagen and Type I Collagen.
Results: We found that over-expression of LMNA or PG by lentiviral gene
delivery leads to defects in differentiation potential. PG-transduced MSCs
present defects in adipogenic and osteogenic potential, The chondrogenic
potential is defective in PG-MSCs, which present a decrease in COL2 and
Aggrecan as revealed by both immunohistochemystry and Real-Time PCR.
LMNA and PG-transduced MSCs have an increase in hypertrophy markers
(MMP-13 and Type X Collagen) during chondrogenic differentiation, as
well as a decrease in manganese superoxide dismutase (MnSODM) and an
increase of mitochondrial MnSODM-dependent reactive oxygen species
(ROS). ROS synthesis was partially (51%) and totally reverted by N-Acetyl
Cystein, ROS scavenger, (NAC) at 20 and 40 mg/mL respectively for 1 hour in
culture. In addition, defects in chondrogenesis detected by immunohis-
tochemestry and Real Time-PCR are partially reversed by incubations with
NAC at 40 mg/mL for 1 hour.
Conclusions: Our results suggest that OA process could be enhanced by
defects in stem cell differentiation, partially due to imbalance in oxidative
stress.
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SYNGENEIC, MINOR MISMATCHED, AND MAJOR MISMATCHED
TRANSPLANTATION OF MESENCHNMAL STEM CELLS DERIVED FROM
SYNOVIUM IN A RAT MASSIVE MENISCAL DEFECT MODEL
M. Okuno 1,2, I. Sekiya 3, S. Yoshiya 2, T. Muneta 1. 1Orthopaedic Surgery,
Tokyo Med. ana Dental Univ., Tokyo, Japan; 2Orthopaedic Surgery, Hyogo
Coll. of Med., Hyogo, Japan; 3Cartilage Regeneration, Tokyo Med. ana
Dental Univ., Tokyo, JapanPurpose: We previously reported that intraarticular injection of mesen-
chymal stem cells (MSCs) derived from synovium promoted meniscal
regeneration in a rat massive meniscal defect model
Great number of reports described that bone marrow MSCs had immu-
noprivileged effects as well as immunosuppressive effects and that allo-
geneic transplantation of bone marrow MSCs enhanced regeneration in
injury models. However, this is still controversial, and the opposite results
were also reported. As far as synovial MSCs, the inﬂuence of allogeneic
transplantation have not been investigated at all.
In this study, we performed syngeneic transplantation and allogeneic
transplantation of synovial MSCs into the knee joints whose medial
menisci were removed. The area of regenerated menisci were compared
among the allogeneic transplantation groups, the major antigen mismatch
group and the minor antigen mismatch group.
Methods: Cell isolation and culture. This study was approved by institu-
tional animal use committee. Synoviumwas harvested from the knee joint
of 3 strains, F344, Lewis, and ACI rats. After collagenase digestion, nucle-
ated cells derived from synoviumwere expanded and colony forming cells
were collected for transplantation.
Meniscectomy: As recipients, only F344 rats at 10-12 weeks of age were
used. Under anesthesia, a straight incisionwasmade on the anterior side of
the right knee, the anteromedial side of the joint capsule was cut, and the
anterior horn of the medial meniscus was dislocated anteriorly with
a forceps. The meniscus was then cut vertically at the level of medial
collateral ligament, and anterior half of medial meniscus was removed.
Transplantation: Immediately after the skin incision was closed, 5x106
synovial MSCs in 50 ml PBS were injected into the right knee joint of F344
rats. Transplantation of synovial MSCs derived from F344 rat is a syngeneic
model. Transplantation of synovial MSCs derived from Lewis rat is a minor
antigen mismatch model, in which histocompatibility antigens differ partly.
Transplantation of synovial MSCs derived from ACI rat is a major antigen
mismatch model, in which histocompatibility antigens differ greatly.
Macroscopic and microscopic features for menisci were examined, and
regenerative area ofmenisci wasmeasured 4weeks after the surgery. (n¼6).
Results :In the case of synovial MSCs derived from F344 and Lewis rat were
transplanted, into the knee of F344 rat, the regenerative areawas signiﬁcantly
larger in the transplantation side than in the contrateral side (n¼6; p¼0.034).
Contrarily, in the case of synovialMSCsderived fromACI ratwere transplanted,
into thekneeof F344 rat, therewasno signiﬁcantdifferenceof the regenerative
area between in the transplantation side and in the contralateral side. The
regenerative area of medial meniscus in the ACI transplantation group was
signiﬁcantly smaller than in the F344 and ACI groups (n¼6; p<0.03).
Conclusion: For regeneration of removed meniscus, similar results were
obtained between the syngeneic transplantation and the minor mismatch
transplantation model. In the major mismatch model, the results were
inferior to the other models.
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CHONDROGENIC DIFFERENTIATION POTENTIAL OF CD56+ SATELLITE
CELL AND PDGFRa+ MESENCHYMAL STEM CELL DERIVED FROM
HUMAN SKELETAL MUSCLE
T. Oishi 1, A. Uezumi 2, A. Kanaji 1, K. Tsuchida 2, H. Yamada 1. 1Dept. of
Orthopaedics, Fujita Hlth.Univ., Sch. of Med., Toyoake-city, Aichi, Japan;
2Div. for Therapies against Intractable Disease, Inst. for Comprehensive
Med. Sci., Fujita Hlth.Univ., Toyoake-city, Aichi, Japan
Purpose: We recently identiﬁed that murine-derived platelet derived
growth factor-a positive mesenchymal stem cells (PDGFRa+ cells) have the
capacity for adipogenic and osteogenic differentiation in vitro and vivo
(Nature Cell, 2010). We also previously reported that two distinct stem cells,
CD56+ satellite cells and PDGFRa+ cells were identiﬁed in human skeletal
muscle and the human PDGFRa+ cells showed successful engraftment and
bone-like tissue formation in vivo. However, chondrogenic differentiation
potential of human skeletal muscle-derived stem cell is still unknown. The
purpose of this study is that the CD56+ satellite cells and PDGFRa+
mesenchymal stem cells derived from human skeletal muscle are evaluated
for their capacity for chondrogenic differentiation in vitro.
Methods:In this study, we used the human muscular tissue of patients
with osteoarthritis of hip, after informed consent were obtained at the
time of hip surgery. After enzymatic digestion of human skeletal muscle,
